Melanins and melanogenesis: methods, standards, protocols

被引:361
作者
d'Ischia, Marco [1 ]
Wakamatsu, Kazumasa [2 ]
Napolitano, Alessandra [1 ]
Briganti, Stefania [3 ]
Garcia-Borron, Jose-Carlos [4 ]
Kovacs, Daniela [3 ]
Meredith, Paul [5 ]
Pezzella, Alessandro [1 ]
Picardo, Mauro [3 ]
Sarna, Tadeusz [6 ]
Simon, John D. [7 ]
Ito, Shosuke [2 ]
机构
[1] Univ Naples Federico II, Dept Chem Sci, Naples, Italy
[2] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi, Japan
[3] San Gallicano Dermatol Inst, Cutaneous Physiopathol Lab, Rome, Italy
[4] Univ Murcia, Sch Med, Dept Biochem & Mol Biol, Murcia, Spain
[5] Univ Queensland, Sch Math & Phys, Ctr Organ Photon & Elect, Brisbane, Qld, Australia
[6] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland
[7] Univ Virginia, Dept Chem, Charlottesville, VA USA
关键词
melanin analysis; melanin synthesis; melanin isolation; melanin spectral characterization; melanogenesis enzymes; method standardization; CELL LUNG-CANCER; EML4-ALK FUSION GENE; MALIGNANT-MELANOMA; THERAPEUTIC TARGET; COLON-CANCER; MUTATION; BRAF; INHIBITION; VARIANTS; CHINESE;
D O I
10.1111/pcmr.12121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite considerable advances in the past decade, melanin research still suffers from the lack of universally accepted and shared nomenclature, methodologies, and structural models. This paper stems from the joint efforts of chemists, biochemists, physicists, biologists, and physicians with recognized and consolidated expertise in the field of melanins and melanogenesis, who critically reviewed and experimentally revisited methods, standards, and protocols to provide for the first time a consensus set of recommended procedures to be adopted and shared by researchers involved in pigment cell research. The aim of the paper was to define an unprecedented frame of reference built on cutting-edge knowledge and state-of-the-art methodology, to enable reliable comparison of results among laboratories and new progress in the field based on standardized methods and shared information.
引用
收藏
页码:616 / 633
页数:18
相关论文
共 36 条
  • [1] BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site
    Bauer, Juergen
    Buettner, Petra
    Murali, Rajmohan
    Okamoto, Ichiro
    Kolaitis, Nicholas A.
    Landi, Maria T.
    Scolyer, Richard A.
    Bastian, Boris C.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (02) : 345 - 351
  • [2] KIT Gene Mutations and Copy Number in Melanoma Subtypes
    Beadling, Carol
    Jacobson-Dunlop, Erick
    Hodi, F. Stephen
    Le, Claudia
    Warrick, Andrea
    Patterson, Janice
    Town, Ajia
    Harlow, Amy
    Cruz, Frank, III
    Azar, Sharl
    Rubin, Brian P.
    Muller, Susan
    West, Rob
    Heinrich, Michael C.
    Corless, Christopher L.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (21) : 6821 - 6828
  • [3] Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
    Butrynski, James E.
    D'Adamo, David R.
    Hornick, Jason L.
    Dal Cin, Paola
    Antonescu, Cristina R.
    Jhanwar, Suresh C.
    Ladanyi, Marc
    Capelletti, Marzia
    Rodig, Scott J.
    Ramaiya, Nikhil
    Kwak, Eunice L.
    Clark, Jeffrey W.
    Wilner, Keith D.
    Christensen, James G.
    Jaenne, Pasi A.
    Maki, Robert G.
    Demetri, George D.
    Shapiro, Geoffrey I.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) : 1727 - 1733
  • [4] KIT as a Therapeutic Target in Metastatic Melanoma
    Carvajal, Richard D.
    Antonescu, Cristina R.
    Wolchok, Jedd D.
    Chapman, Paul B.
    Roman, Ruth-Ann
    Teitcher, Jerrold
    Panageas, Katherine S.
    Busam, Klaus J.
    Chmielowski, Bartosz
    Lutzky, Jose
    Pavlick, Anna C.
    Fusco, Anne
    Cane, Lauren
    Takebe, Naoko
    Vemula, Swapna
    Bouvier, Nancy
    Bastian, Boris C.
    Schwartz, Gary K.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2327 - 2334
  • [5] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2507 - 2516
  • [6] Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases
    Chi, Zhihong
    Li, Siming
    Sheng, Xinan
    Si, Lu
    Cui, Chuanliang
    Han, Mei
    Guo, Jun
    [J]. BMC CANCER, 2011, 11
  • [7] A Network of Cancer Genes with Co-Occurring and Anti-Co-Occurring Mutations
    Cui, Qinghua
    [J]. PLOS ONE, 2010, 5 (10):
  • [8] Distinct sets of genetic alterations in melanoma
    Curtin, JA
    Fridlyand, J
    Kageshita, T
    Patel, HN
    Busam, KJ
    Kutzner, H
    Cho, KH
    Aiba, S
    Bröcker, EB
    LeBoit, PE
    Pinkel, D
    Bastian, BC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) : 2135 - 2147
  • [9] High Throughput Mass Spectrometry-Based Mutation Profiling of Primary Uveal Melanoma
    Daniels, Anthony B.
    Lee, Joo-Eun
    MacConaill, Laura E.
    Palescandolo, Emanuele
    Van Hummelen, Paul
    Adams, Scott M.
    DeAngelis, Margaret M.
    Hahn, William C.
    Gragoudas, Evangelos S.
    Harbour, J. William
    Garraway, Levi A.
    Kim, Ivana K.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (11) : 6991 - 6996
  • [10] BRAF, a Target in Melanoma Implications for Solid Tumor Drug Development
    Flaherty, Keith T.
    McArthur, Grant
    [J]. CANCER, 2010, 116 (21) : 4902 - 4913